Global Ponatinib Drugs Market Insights, Forecast to 2025

Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).
The global Ponatinib Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ponatinib Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Ponatinib Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ponatinib Drugs in these regions.
This research report categorizes the global Ponatinib Drugs market by top players/brands, region, type and end user. This report also studies the global Ponatinib Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
ARIAD Pharmaceuticals

Market size by Product
45mg
15mg
Market size by End User
CML
ALL

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Ponatinib Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Ponatinib Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ponatinib Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ponatinib Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ponatinib Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ponatinib Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Ponatinib Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Ponatinib Drugs Market Size Growth Rate by Product
1.4.2 45mg
1.4.3 15mg
1.5 Market by End User
1.5.1 Global Ponatinib Drugs Market Size Growth Rate by End User
1.5.2 CML
1.5.3 ALL
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Ponatinib Drugs Market Size
2.1.1 Global Ponatinib Drugs Revenue 2014-2025
2.1.2 Global Ponatinib Drugs Sales 2014-2025
2.2 Ponatinib Drugs Growth Rate by Regions
2.2.1 Global Ponatinib Drugs Sales by Regions
2.2.2 Global Ponatinib Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Ponatinib Drugs Sales by Manufacturers
3.1.1 Ponatinib Drugs Sales by Manufacturers
3.1.2 Ponatinib Drugs Sales Market Share by Manufacturers
3.1.3 Global Ponatinib Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Ponatinib Drugs Revenue by Manufacturers
3.2.1 Ponatinib Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Ponatinib Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Ponatinib Drugs Price by Manufacturers
3.4 Ponatinib Drugs Manufacturing Base Distribution, Product Types
3.4.1 Ponatinib Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ponatinib Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Ponatinib Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Ponatinib Drugs Sales by Product
4.2 Global Ponatinib Drugs Revenue by Product
4.3 Ponatinib Drugs Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Ponatinib Drugs Breakdown Data by End User

6 North America
6.1 North America Ponatinib Drugs by Countries
6.1.1 North America Ponatinib Drugs Sales by Countries
6.1.2 North America Ponatinib Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Ponatinib Drugs by Product
6.3 North America Ponatinib Drugs by End User

7 Europe
7.1 Europe Ponatinib Drugs by Countries
7.1.1 Europe Ponatinib Drugs Sales by Countries
7.1.2 Europe Ponatinib Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ponatinib Drugs by Product
7.3 Europe Ponatinib Drugs by End User

8 Asia Pacific
8.1 Asia Pacific Ponatinib Drugs by Countries
8.1.1 Asia Pacific Ponatinib Drugs Sales by Countries
8.1.2 Asia Pacific Ponatinib Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Ponatinib Drugs by Product
8.3 Asia Pacific Ponatinib Drugs by End User

9 Central & South America
9.1 Central & South America Ponatinib Drugs by Countries
9.1.1 Central & South America Ponatinib Drugs Sales by Countries
9.1.2 Central & South America Ponatinib Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Ponatinib Drugs by Product
9.3 Central & South America Ponatinib Drugs by End User

10 Middle East and Africa
10.1 Middle East and Africa Ponatinib Drugs by Countries
10.1.1 Middle East and Africa Ponatinib Drugs Sales by Countries
10.1.2 Middle East and Africa Ponatinib Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Ponatinib Drugs by Product
10.3 Middle East and Africa Ponatinib Drugs by End User

11 Company Profiles
11.1 ARIAD Pharmaceuticals
11.1.1 ARIAD Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 ARIAD Pharmaceuticals Ponatinib Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 ARIAD Pharmaceuticals Ponatinib Drugs Products Offered
11.1.5 ARIAD Pharmaceuticals Recent Development

12 Future Forecast
12.1 Ponatinib Drugs Market Forecast by Regions
12.1.1 Global Ponatinib Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Ponatinib Drugs Revenue Forecast by Regions 2019-2025
12.2 Ponatinib Drugs Market Forecast by Product
12.2.1 Global Ponatinib Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Ponatinib Drugs Revenue Forecast by Product 2019-2025
12.3 Ponatinib Drugs Market Forecast by End User
12.4 North America Ponatinib Drugs Forecast
12.5 Europe Ponatinib Drugs Forecast
12.6 Asia Pacific Ponatinib Drugs Forecast
12.7 Central & South America Ponatinib Drugs Forecast
12.8 Middle East and Africa Ponatinib Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ponatinib Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

1.1 Methodology/Research Approach

Our research methodology implements a mix of primary as well as secondary research. Our projects are initiated with secondary research, where we refer to a variety of sources including trade databases; government published documents, investor presentations, company annual reports, white papers, and paid databases.

1.1.1 Research Programs/Design

1.1.2 Market Size Estimation

Post the initial data mining stage, we gather our findings and analyse them, filtering out relevant insights. These are evaluated across teams and by our in-house SMEs. Along with data mining, we also initiate the primary research phase in which we interact with companies operating within the market space.

To evaluate the wholeness of the market, we interact (via email or telephone) with players who are responsible in adding value to the final product. Additionally, we interact with related industries to understand the external factors that can drive/hamper a market. We also make it a point to evaluate various economic parameters, which typically, have an impact on the purchasing choices of individuals as well as companies.

Post these stages, data are cross-verified with the companies that operate in a market space. It is important for us to study these companies in detail, to understand their existing performance and future strategies which will define the market in the coming years.

All this data is collected and evaluated by our analysts. Post the preparation of the report and data analysis, the findings are presented to our in-house experts who then eliminate discrepancies (if any).

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares splits, and breakdowns have been determined using secondary sources and verified through primary sources.

1.2 Data Source

1.2.1 Secondary Sources

In the secondary research process, various secondary sources, such as D&B Hoovers, Bloomberg BusinessWeek, and Factiva, have been referred to, for identifying and collecting information for this study. Secondary sources included annual reports, press releases, and investor presentations of companies; whitepapers, certified publications, and articles by recognized authors; gold standard and silver standard websites; regulatory bodies; trade directories; and databases.

List of secondary sources include but are not limited to:

  • Academic Journals
  • Census.gov
  • Bloomberg
  • Company Annual Report
  • Hoovers

1.2.1.1 Preliminary data mining

Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. For comprehensive understanding of the market, it is essential to understand the complete value chain and in order to facilitate this; we collect data from raw material suppliers, distributors as well as buyers.

Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered. As a result, the material developed contains a wide range of original data that is then further cross-validated and authenticated with published sources.

1.2.2 Primary Sources

This is the final step in estimating and forecasting for our reports. Exhaustive primary interviews are conducted, on face to face as well as over the phone to validate our findings and assumptions used to obtain them. Interviewees are approached from leading companies across the value chain including suppliers, technology providers, domain experts and buyers so as to ensure a holistic and unbiased picture of the market. These interviews are conducted across the globe, with language barriers overcome with the aid of local staff and interpreters. Primary interviews not only help in data validation, but also provide critical insights into the market, current business scenario and future expectations and enhance the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants (KIPs) which typically include:

  • Market leading companies
  • Raw material suppliers
  • Product distributors
  • Buyers

The key objectives of primary research are as follows:

  • To validate our data in terms of accuracy and acceptability
  • To gain an insight in to the current market and future expectations

1.2.3 Statistical model

Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise.

Econometric models are generally used for short-term forecasting, while technological market models are used for long-term forecasting. These are based on an amalgamation of technology landscape, regulatory frameworks, economic outlook and business principles. A bottom-up approach to market estimation is preferred, with key regional markets analyzed as separate entities and integration of data to obtain global estimates. This is critical for a deep understanding of the industry as well as ensuring minimal errors. Some of the parameters considered for forecasting include:

  • Market drivers and restrains, along with their current and expected impact
  • Raw material scenario and supply v/s price trends
  • Regulatory scenario and expected developments
  • Current capacity and expected capacity additions up to 2026

We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate.

1.2.4 Data Triangulation

After arriving at the overall market size using the market size estimation processes as explained above, the market was split into several segments and sub segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying several factors and trends from both the demand and supply sides.

1.2.5 Report Objectives

  • To define, describe, and forecast the market by segmentations, and region
  • To provide detailed information about the major factors (drivers, restraints, opportunities, and challenges) influencing the growth of the market
  • To analyze the sub-segments with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide the competitive landscape of the market
  • To forecast the revenues of the market segments with respect to the major regions, such as North America, Europe, Asia Pacific (APAC), and RoW
  • To profile the key players and comprehensively analyze their recent developments and positioning in the market
  • To analyze competitive developments, such as mergers and acquisitions, new product developments, and Research and Development (R&D) activities, in the market
Purchase
Specs
Release date:September 26, 2019
Last updated:January 1, 1970
File Type:PDF
Category:Machinery & Equipment
Number Of Pages:100-150
Specs
Release date:September 26, 2019
Last updated:January 1, 1970
File Type:PDF
Category:Machinery & Equipment
Number Of Pages:100-150

Purchase Report

Purchase

Download Category:

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why SMR?

Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision

Recommendations

Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements